Biotech

Ellis Martin Report: Defence Therapeutics Inc. (CNSX:DTC) Dr. Moutih Rafei-Developing Vaccines and Platform Technologies for the Treatment of Cancer

🕔6/12/2024 10:47:17 AM

Join Ellis Martin and Money Talk Radio for a conversation with Dr. Moutih Rafei, Chief Science Officer of Defence Therapeutics (CNSX:DTC) (FRA:DTC) (OTCMKTS:DTCFF).

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) Promarker Technology Used For Diagnosing Plant Dieback

🕔5/16/2024 8:17:05 AM

Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics is pleased to confirm the successful collaboration with Curtin University's Centre for Crop and Disease Management (CCDM), with researchers making an important breakthrough in understanding how dieback impacts plants.

Read Full Article

Apiam Animal Health Limited (ASX:AHX) Investor Update

🕔5/8/2024 9:05:09 AM

Apiam Animal Health Limited (ASX:AHX) is pleased to provide an update on Apiam Animal Health's year-to-date performance for FY24 up until 31 March 2024 (FY24 YTD).

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) March 2024 Quarterly Activities Report

🕔4/17/2024 8:24:54 AM

Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics is pleased to provide the following update on its business activities for the three months to 31 March 2024.

Read Full Article

VIDEO: Apiam Animal Health Limited (ASX:AHX) MD Dr. Chris Richards Speaks with ABN Newswire on Revenue Growth in the Business

🕔4/8/2024 1:05:00 PM

Apiam Animal Health Limited (ASX:AHX) MD Dr. Chris Richards Speaks with ABN Newswire on Revenue Growth in the Business and the consolidation of acquisitions made by the company over the last two years.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) Investor Presentation

🕔3/28/2024 11:28:09 AM

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to release a copy of the presentation to be provided by Dr Richard Lipscombe to Jefferies Institutional Clients on 28 March 2024.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) Signs With Oxford University to Validate Test for Endometriosis

🕔3/25/2024 8:26:03 AM

Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics, is pleased to announce it has signed a Material Transfer Agreement with the globally-respected University of Oxford to acquire approximately 600 patient plasma samples for its endometriosis study.

Read Full Article